AACE 2019 Annual Conference

MEET-THE-EXPERTS SESSION II

Management of Patients with Radioactive Refractory Thyroid Cancer

4/25/2019
3:30 PM - 4:30 PM
Location: Convention Center 515 B

Andrew Gianoukakis, MD

Professor
Harbor-UCLA

Andrew G. Gianoukakis MD is a Professor of Medicine in the Geffen School of Medicine at
UCLA. Dr. Gianoukakis is a clinician educator and clinical researcher. He serves as
program director of the Harbor-UCLA Endocrinology and Metabolism training program and
has served on the Association of Program Directors in Endocrinology and Metabolism
(APDEM) council since 2015. Dr. Gianoukakis heads the thyroid unit at Harbor-UCLA
Medical Center and directs the Thyroid Nodule Aspiration and Thyroid Oncology clinics. He
directs a research team performing phase II-III clinical thyroid cancer trials and studies. He
is a member of the International Thyroid Oncology Group (ITOG) serving as a member of
the Board as well as chair of ITOG’s Membership Committee. Additionally, Dr. Gianoukakis
serves as secretary of the Southern California Thyroid Cancer Consortium (SCThyCC), and
advisory board member of the National Graves’ Disease and Thyroid Foundation (GDATF)
and the Thyroid Cancer Survivors Association (ThyCa).

Presentation(s):

Send Email for Andrew Gianoukakis

Hossein Gharib, MD

Professor
Mayo Clinic

Hossein Gharib, MD, a Professor of Medicine at Mayo Clinic College of Medicine, is an international authority on thyroid disorders.
He is the Dean of Endocrine Unversity and a Master of American College of Endocrinology. He is a past president of AACE, American College of Endocrinology & American Thyroid Association.

Presentation(s):

Send Email for Hossein Gharib


Assets

Surveillance and Treatment of Patients with Radioactive Refractory Differentiated Thyroid Cancer

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Surveillance and Treatment of Patients with Radioactive Refractory Differentiated Thyroid Cancer